Recommended Pages at thestreet.com
MOH Stock | Molina Healthcare Inc. Stock Downgraded (MOH) - TheStreet
thestreet.com — “Molina Healthcare (NYSE:MOH) has been downgraded by TheStreet Ratings from from a buy to hold..” View full resource at thestreet.com
Most Recently Shared on April 13, 2012 at 2:16 pm By:
Molina Healthcare Inc. Stock Downgraded (MOH): By TheStreet Wire 04/13/12 - 06:00 AM EDT NEW YORK (TheStreet) --... http://t.co/WT6ekcA3
6 Leadership Tips From Ford CEO Alan Mulally - TheStreet
thestreet.com — “Engage workers and pull together to implement a singular vision, he says.” View full resource at thestreet.com
Most Recently Shared on April 3, 2012 at 5:04 pm By:
davisliumd Physician, Doctor, and Family Medicine Doctor
Learnings for MD leaders? http://t.co/VbrKLgAa
EASL Gives Wall Street's Privileged Investors Sneaky Preview to Key Hep C Data - TheStreet
thestreet.com — “You thought investing in Hep C stocks ahead of a key European conference is fair? Guess again, thanks to EASL and its selective disclosure policy.” View full resource at thestreet.com
Most Recently Shared on March 20, 2012 at 12:49 pm By:
Ivan Oransky Doctor and Health Communicator
A lot to wonder about http://t.co/ew8ZoEvl RT @mslopatto: Paging @ivanoransky: @adamfeuerstein hates EASL embargoes http://t.co/PQBccRlb
Elan's Alzheimer's-Fueled Run Means Investors Are Forgetting the Past - TheStreet
thestreet.com — “Remembering the failed back story of Elan's Alzheimer's drug bapineuzumab as phase III trial results loom.” View full resource at thestreet.com
Most Recently Shared on March 19, 2012 at 4:20 pm By:
Elan's Alzheimer's-Fueled Run Means Investors Are Forgetting the Past: BOSTON (TheStreet) -- "@adamfeuerstein Wo... http://t.co/PGywWsXX
Foundation Of UMDNJ Receives Grand Challenges Tuberculosis Biomarkers Grant - TheStreet
thestreet.com — “Foundation Of UMDNJ Receives Grand Challenges Tuberculosis Biomarkers Grant - TheStreet” View full resource at thestreet.com
Most Recently Shared on March 16, 2012 at 3:00 pm By:
Neil Kothari, M.D. Doctor and Physician
NJMS' Dr. David Alland Receives Grand Challenges Tuberculosis Biomarkers Grant from Gates Foundation - TheStreet http://t.co/uBnj9XAC
Peregrine Pharma Cancer Drug Unmasked by Independent Review - TheStreet
thestreet.com — “Peregrine's lung cancer drug doesn't survive an unbiased reivew of phase II trial data.” View full resource at thestreet.com
Most Recently Shared on March 9, 2012 at 9:54 pm By:
Peregrine Pharma Cancer Drug Unmasked by Independent Review: if !IE--endif--Content on this page requires a newe... http://t.co/MJe60dTX
TheStreet TV - HD Videos With CEOs, Analysts, Fund Managers and More
thestreet.com — “HD video interviews with policy makers, entrepreneurs, star fund managers, Wall St. analysts, CEOs, and stock market commentators.” View full resource at thestreet.com
Most Recently Shared on January 13, 2012 at 7:00 pm By:
JP Morgan Miss Causes Market Anxiety: JP Morgan disappoints the market with its revenue numbers. No rioting by b... http://t.co/KJVmdmGO
Tonix Pharmaceuticals To Present At Biotech Showcase And OneMedForum Conferences In San Francisco On January 9 And 10, 2012 - TheStreet
thestreet.com — “Tonix Pharmaceuticals Holding Corp (OTCBB:TNXP) (“TONIX”), a specialty pharmaceutical company developing therapies for challenging disorders of the central nervous system (“CNS”), including.” View full resource at thestreet.com
Most Recently Shared on January 4, 2012 at 1:05 pm By:
Tonix Pharmaceuticals To Present At Biotech Showcase And OneMedForum ... - http://t.co/8y7ZtDjX (press release) http://t.co/yt8sr6SJ
Best Biotech CEO of 2011 -- Vote Here - TheStreet
thestreet.com — “There are five nominees, and the winner will be chosen in a week.” View full resource at thestreet.com
Most Recently Shared on December 6, 2011 at 2:38 pm By:
Counting money? MT @adamfeuerstein $SPPI leads early voting for Best #Biotech CEO 2011. Where are $VRUS CEO fans? --> http://t.co/wUq7SHZ0
Medtronic Receives FDA Approval For Next Generation Professional Continuous Glucose Monitoring - TheStreet
thestreet.com — “Medtronic, Inc (NYSE:MDT) today announced the Food and Drug Administration (FDA) approval of iPro ®2, a next generation Professional continuous glucose monitoring (CGM) system and the latest in a series of recent.” View full resource at thestreet.com
Most Recently Shared on November 22, 2011 at 5:03 pm By:
Newsflash: Medtronic's new iPro CGM Approved by FDA http://t.co/PMKoRSwK Use of this #bgnow tool is controlled by the doctor #diabetes
Exelixis Falls on FDA Prostate Cancer Trial Design Setback - TheStreet
thestreet.com — “Exelixis faces a delay in reaching approval for its prostate cancer drug cabozantinib.” View full resource at thestreet.com
Most Recently Shared on October 31, 2011 at 11:39 pm By:
john clay mchugh Surgeon, Urologist, Physician, and Doctor
Exelixis Falls on FDA Prostate Cancer Trial Design Setback: SOUTH SAN FRANCISCO, Calif. (TheStreet) -- Exelixis ... http://t.co/IJfLE0Sm
Target Commits To Selling Only Sustainable And Traceable Seafood By 2015 - TheStreet
thestreet.com — “Target Corp (NYSE:TGT) today announced it is committed to selling only sustainable and traceable seafood in its stores by 2015.” View full resource at thestreet.com
Most Recently Shared on October 13, 2011 at 10:25 pm By:
Target to sell sustainable seafood. http://t.co/C8YoispH
Gilead Quad HIV Drug Meets Second Study Goal - TheStreet
thestreet.com — “Gilead will seek FDA approval of its four-in-one HIV pill by the end of the year.” View full resource at thestreet.com
Most Recently Shared on September 19, 2011 at 9:46 pm By:
Gilead Quad HIV Drug Meets Second Study Goal: FOSTER CITY, Calif. (TheStreet) -- Gilead Sciences' experimental s... http://t.co/kXQ5zPje
Study Says Many Studies Are Misleading - TheStreet
thestreet.com — “Studies about medicine can be misleading, says a study that studied studies on medicine.” View full resource at thestreet.com
Most Recently Shared on August 30, 2011 at 5:04 pm By:
Tom Heston, MD Doctor, Family Medicine Doctor, and Physician
Study Says Many Studies Are Misleading - TheStreet.com http://t.co/FA5BFV5 #familyhealth
FDA Rejects NuPathe Migraine Patch - TheStreet
thestreet.com — “NuPathe may need to conduct additional studies before resubmitting Zelrix for approval again.” View full resource at thestreet.com
Most Recently Shared on August 30, 2011 at 12:43 pm By:
FDA Rejects NuPathe Migraine Patch: CONSHOHOCKEN, Pa. (TheStreet) -- U.S. regulators rejected NuPathe's migraine... http://t.co/CjQasgc
